Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas13 has drawn broad interest to control gene expression and cell fate at the RNA level in general. Apart from RNA interference mediated by its endonuclease activity, the nuclease-deactivated form of Cas13 further provides a versatile RNA-guided RNA-targeting platform for manipulating kinds of RNA modifications post-transcriptionally. Chemical modifications modulate various aspects of RNA fate, including translation efficiency, alternative splicing, RNA-protein affinity, RNA-RNA interaction, RNA stability and RNA translocation, which ultimately orchestrate cellular biologic activities. This review summarizes the history of the CRISPR-Cas13 system, fundamental components of RNA modifications and the related physiological and pathological functions. We focus on the development of epi-transcriptional editing toolkits based on catalytically inactive Cas13, including RNA Editing for Programmable A to I Replacement (REPAIR) and xABE (adenosine base editor) for adenosine deamination, RNA Editing for Specific C-to-U Exchange (RESCUE) and xCBE (cytidine base editor) for cytidine deamination and dm6ACRISPR, as well as the targeted RNA methylation (TRM) and photoactivatable RNA m6A editing system using CRISPR-dCas13 (PAMEC) for m6A editing. We further highlight the emerging applications of these useful toolkits in cell biology, disease and imaging. Finally, we discuss the potential limitations, such as off-target editing, low editing efficiency and limitation for AAV delivery, and provide possible optimization strategies.

Enhancing the RNA Engineering Toolkit

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

Programmable RNA targeting with CRISPR-Cas13

Engineered RNA‐binding Proteins: Studying and Controlling RNA Regulation

Engineering synthetic RNA devices for cell control

Advances in CRISPR-Cas Systems for RNA Targeting, Tracking and Editing.

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

Progress of CRISPR-based programmable RNA manipulation and detection.

Advances in CRISPR-Cas systems for RNA targeting, tracking and editing

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Controlling CRISPR-Cas9 by guide RNA engineering

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

RNA-Dependent RNA Targeting by CRISPR-Cas Systems: Characterizations and Applications

An Artificial Small RNA Editor by Chimeric dsRNase with RNA Binding Protein

Expanded toolkits for RNA circularization

Programmable RNA base editing via targeted modifications

Improving transgene expression and CRISPR-Cas9 efficiency with molecular engineering-based molecules

Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme